Add this topic to your myFT Digest for news straight to your inbox
Trials impress though safety and price questions remain
As big pharma bets huge sums on the next breakthrough drugs, some investors fear another bubble
Deal marks return to big-ticket M&A after the defeat of Allergan bid last year
Stocks hit new intraday highs on Monday on the back of a strong earnings season and Friday’s jobs report
International Edition